Tenderwize
Retour à la recherche

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Katholieke Universiteit te Leuven·Leuven, Belgium·Expired · Aug 10, 2026·Neg W Call·Services
Structured notice only
Titre original de l'avis

Belgium – Research and experimental development services – QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry

30/100

Score d'opportunité

Needs reviewMedium complexity
ServicesExpired
Pourquoi ce score ?

Opportunité

30 / 100

Complexité

50 / 100

Facteurs de risque

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Katholieke Universiteit te Leuven
Pays
Belgique
CPV
73100000 - Research and experimental development services
Date limite
Aug 10, 2026

Aperçu

Moderate opportunity

Faits clés

  • Services contract
  • 1 lot
  • Duration 1 YEAR
  • Perform iterative Design-Make-Test-Analyze (DMTA) cycles for optimization of early hit structures.
  • Apply advanced medicinal chemistry techniques.
Afficher le résumé complet

Single-lot negotiated procedure for appointing a Contract Research Organization (CRO) to optimize early hit structures through iterative Design-Make-Test-Analyze (DMTA) cycles in advanced medicinal chemistry. The buyer is KU Leuven, acting for itself and VIB. The contract duration is 1 year. No estimated value is provided. The procedure is a competitive negotiation without prior call (neg-w-call), likely limiting candidates to 3-4. Award criteria (price and quality) will be detailed in the second stage. The tender is published in English, with submission via the e-procurement platform. EU funding status is inconsistent: structured data indicates EU-funded, but the XML notice states no EU funds.

Risques

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • CRO must be capable of conducting advanced medicinal chemistry DMTA cycles.

Administrative

  • Electronic submission via the e-procurement platform is required.
  • Tender must be submitted in English (notice language).

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Price (weight not specified)Quality (weight not specified)

Acheteur

Localisation

Leuven, BEL

Profil acheteur

Ouvrir le profil

Identifiant

0419052173_5132

Activité

Education

Lots (1)

LOT-0001

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Appointment of a CRO to perform iterative DMTA cycles (Design-Make-Test-Analyze) for optimizing early hit structures in advanced medicinal chemistry. The contract is for services related to research and experimental development (CPV 73100000). Duration: 1 year. Place of performance: Leuven, Belgium (BE242).

ServicesEU fundedElectronic submission

Localisation

BE242, Belgium

Durée

1 YEAR

Catégorie

Research

Critères d'attribution

Best price-quality ratio

Date limite

Expired Aug 10, 2026

Détails de la procédure

Date de publication
08 Jul 2026
Langues
Dutch, English

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
473822-2026

Documents (2)

Appels d'offres similaires